Nika Pharmaceuticals Inc.
NIKA · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $708,220 | $1,026,371 | $516,613 |
| - Cash | $6 | $16 | $19 | $2 |
| + Debt | $0 | $0 | $269 | $239 |
| Enterprise Value | – | $708,205 | $1,026,621 | $516,851 |
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | – | – | 100% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | 100% |
| EBITDA | -$8 | -$18 | -$13 | $11 |
| % Margin | – | – | – | -6,827.6% |
| Net Income | -$8 | -$18 | -$13 | -$12 |
| % Margin | – | – | – | 7,982.7% |
| EPS Diluted | 0 | 0 | 0 | 0 |
| % Growth | – | – | -100% | – |
| Operating Cash Flow | -$9 | -$19 | -$13 | -$12 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$9 | -$19 | -$13 | -$12 |